30-day notice

44642

Federal Register / Vol. 81, No. 131 / Friday, July 8, 2016 / Notices

III. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble.
Dated: June 29, 2016.
Kathryn E. Martin,
Acting Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2016–16067 Filed 7–6–16; 8:45 am]
BILLING CODE 4150–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Dated: July 1, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.

National Institutes of Health
Public Workshop—Iron Screening and
Supplementation of Iron-Replete
Pregnant Women and Young Children
The Office of Dietary
Supplements at the National Institutes
of Health (NIH) is sponsoring an open
public workshop titled, ‘‘Iron Screening
and Supplementation of Iron-replete
Pregnant Women and Young Children,’’
September 28–29, 2016, on the NIH
main campus in Bethesda, Maryland. It
will also be available to be viewed live
or later on-demand as a videocast. The
workshop discussions will focus on the
U.S. and developed countries and will
serve to specify data gaps and research
needs by (1) exploring current
understanding of iron homeostasis in
pregnant women and in young children
(6-24 months); (2) identifying the
challenges associated with measuring
iron status and with screening practices;
and (3) considering emerging issues
associated with routine
supplementation of iron-replete
individuals. All persons are invited to
attend, especially clinical educators,
those who develop clinical
recommendations, health care providers
and researchers. Persons wishing to
attend are required to register in
advance of the conference.
DATES: September 28–29, 2016; 8:30 to
5:15 p.m. (Eastern Time) on the first day
and 8:00 to 12:30 p.m. on the second
day.

asabaliauskas on DSK3SPTVN1PROD with NOTICES

SUMMARY:

National Institutes of
Health, William H. Natcher Building;
Natcher Conference Center, Building 45,
Bethesda, Maryland, 20892.
FOR FURTHER INFORMATION CONTACT: Ms.
Cindy Rooney, Office of Dietary
Supplements, National Institutes of
Health, 6100 Executive Boulevard,
ADDRESSES:

VerDate Sep<11>2014

17:00 Jul 07, 2016

Jkt 238001

Room 3B01, Bethesda, MD 20892–7523,
Email: rooneyc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The
conference is sponsored by the NIH
Office of Dietary Supplements along
with co-sponsors from other federal
agencies. Information about the
conference agenda, registration
procedures, and videocast arrangements
can be found at: https://eventssuport.com/events/NIH_Iron_Workshop.
Through its Iron Initiative, the
National Institutes of Health (NIH)
Office of Dietary Supplements leads
efforts to advance scientific
understanding of iron and health:
https://ods.od.nih.gov/Research/
Iron.aspx.

[FR Doc. 2016–16254 Filed 7–7–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request National Institutes
of Health (NIH) Loan Repayment
Programs; Office of the Director (OD)
Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Division of
Loan Repayment (DLR), the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on February 19, 2016, and page
numbers 8514–8516, and allowed 60
days for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The NIH
may not conduct or sponsor, and the
respondent is not required to respond
to, an information collection that has
been extended, revised, or implemented
on or after October 1, 1995, unless it
displays a currently valid OMB control
number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.

SUMMARY:

PO 00000

Frm 00063

Fmt 4703

Sfmt 4703

Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments or request more
information on the proposed project
contact: Steve Boehlert, Director of
Operations, Division of Loan
Repayment, National Institutes of
Health, 6011 Executive Blvd., Room 206
(MSC 7650), Bethesda, Maryland
20892–7650. Mr. Boehlert may be
contacted via email at BoehlerS@
od.nih.gov or by calling 301–451–4465.
Formal requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: National
Institutes of Health (NIH) Loan
Repayment Programs (LRP). Type of
Information Collection Request:
Revision of a currently approved
collection (OMB No. 0925–0361,
expiration date 06/30/17). Form
Numbers: NIH 2674–1, NIH 2674–2,
NIH 2674–3, NIH 2674–4, NIH 2674–5,
NIH 2674–6, NIH 2674–7, NIH 2674–8,
NIH 2674–9, NIH 2674–10, NIH 2674–
11, NIH 2674–12, NIH 2674–13, NIH
2674–14, NIH 2674–15, NIH 2674–16,
NIH 2674–17, NIH 2674–18, NIH 2674–
19, and NIH 2674–20 (new).
Need and Use of Information
Collection: The NIH makes available
financial assistance, in the form of
educational loan repayment, to M.D.,
Ph.D., Pharm.D., Psy.D., D.O., D.D.S.,
D.M.D., D.P.M., D.C., N.D., O.D., D.V.M.,
or equivalent degree holders who
perform biomedical or behavioral
research in NIH intramural laboratories
or as extramural grantees or scientists
funded by domestic non-profit
organizations for a minimum of two
years (three years for the General
Research LRP) in research areas
supporting the mission and priorities of
the NIH.
The AIDS Research Loan Repayment
Program (AIDS–LRP) is authorized by
section 487A of the Public Health
Service Act (42 U.S.C. 288–1); the
Clinical Research Loan Repayment
Program for Individuals from
Disadvantaged Backgrounds (CR–LRP)
is authorized by section 487E (42 U.S.C.
288–5); the General Research Loan
Repayment Program (GR–LRP) is
authorized by section 487C of the Public
Health Service Act (42 U.S.C. 288–3);
the Clinical Research Loan Repayment
Program (LRP–CR) is authorized by
section 487F (42 U.S.C. 288–5a); the
Pediatric Research Loan Repayment
Program (PR–LRP) is authorized by

E:\FR\FM\08JYN1.SGM

08JYN1

44643

Federal Register / Vol. 81, No. 131 / Friday, July 8, 2016 / Notices
section 487F (42 U.S.C. 288–6); the
Extramural Clinical Research LRP for
Individuals from Disadvantaged
Backgrounds (ECR–LRP) is authorized
by an amendment to section 487E (42
U.S.C. 288–5); the Contraception and
Infertility Research LRP (CIR–LRP) is
authorized by section 487B (42 U.S.C.
288–2); and the Health Disparities
Research Loan Repayment Program
(HD–LRP) is authorized by section 485G
(42 U.S.C. 287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection

better user experience. Recommenders
will no longer be asked to complete a
recommendation form, but to write a
reference letter that comments on the
research skills and the abilities of the
applicant. A general eligibility checklist
(NIH 2674–20) was added at the start of
the application to reduce the likelihood
of ineligible individuals working
through the application only to learn of
their disqualification after submitting
the application. Redundant questions or
statements were eliminated. OMB
approval is requested for 3 years. There
are no costs to respondents other than
their time. The total estimated
annualized burden hours are 33,242.

will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program.
Frequency of Response: Initial
application and one- or two-year
renewal application.
Affected Public: Individuals or
households; Nonprofits; and Businesses
or other for-profit.
Type of Respondents: Physicians,
other scientific or medical personnel,
and institutional representatives.
Questions, required information, and
requested documents remain largely
unchanged. Improvements were made to
the structure and appearance of online
forms to provide applicants with a

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Intramural LRPs
Initial Applicants ...............................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................
Financial Institutions ........................................................................................

Average
burden
hours per
response

Annual burden
hours
requested

40
40
120
8

1
1
1
1

10
1
30/60
15/60

400
40
60
2

208

........................

........................

502

1,650
1,480
4,950
100

1
1
1
1

11
1
30/60
15/60

18,150
1,480
2,475
25

Subtotal .....................................................................................................
Intramural LRPs
Renewal Applicants .........................................................................................
Advisors/Supervisors .......................................................................................
Subtotal .....................................................................................................
Extramural LRPS
Renewal Applicants .........................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................

8,180

........................

........................

22,130

40
40
80

1
1
........................

7
2
........................

280
80
360

1,000
750
3,000

1
1
1

8
1
30/60

8,000
750
1,500

Subtotal .....................................................................................................
Total ...................................................................................................

4,750
13,218

........................
........................

........................
........................

10,250
33,242

Subtotal .....................................................................................................
Extramural LRPs
Initial Applicants ...............................................................................................
Advisors/Supervisors .......................................................................................
Recommenders ................................................................................................
Financial Institutions ........................................................................................

Dated: July 1, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016–16227 Filed 7–7–16; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Estimated
number of
responses per
respondent

National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases: Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as

VerDate Sep<11>2014

17:00 Jul 07, 2016

Jkt 238001

amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, NIDDK Training
Grants Review.

PO 00000

Frm 00064

Fmt 4703

Sfmt 4703

Date: July 26, 2016.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: CAROL J. GOTERROBINSON, PH.D., SCIENTIFIC REVIEW
OFFICER, REVIEW BRANCH, DEA, NIDDK,
NATIONAL INSTITUTES OF HEALTH,
ROOM 7347, 6707 DEMOCRACY
BOULEVARD, BETHESDA, MD 20892–5452,
(301) 594–7791, goterrobinsonc@
extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Program Project on
Gut Microbial Host Interactions.
Date: August 5, 2016.

E:\FR\FM\08JYN1.SGM

08JYN1